Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
Irish Examiner on MSN3d
Regional success story: US firms' nationwide boost for Irish economy
In total, 234 investments creating 13,500 new jobs over the next five years, 59% of which were in regional locations ...
Irish Examiner7d
Innovating beyond boundaries: Sarah O’Keeffe’s career in making medicine
Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...
pharmaphorum8d
Update on Attention Deficit Hyperactivity Disorder (ADHD) treatments
Eli Lilly and Company Ltd. Strattera Summary ... practice lecturer at the School of Pharmacy, University College Cork, Ireland and her research interests are in the field of pharmacoepidemiology ...
Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
The Sunday Business Post8d
Live News: Iseq closes in the green; FG senator Martin Conway resigns after arrest
A broad measure of Asian equities slipped, pressured by sell-offs in Hong Kong and mainland China. Futures for the S&P 500 ...
The Motley Fool4d
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...
pharmaphorum1d
Eli Lilly plans €400m Irish plant that will create 800 jobs
Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines ...